TXLNA and pancreatic adenocarcinoma: Meanwhile, analysis results from ICGA_Seq data demonstrated that the increased TXLNA expression group had favourable OS (p=0.0015; HR: 0.5786; 95% CI: 0.4128–0.8109; Figure 2(e)) and favourable DFI (p=0.0448; HR: 0.6577; 95% CI: 0.4367–0.9904; Figure 2(f)) for PAAD patients.